Academic drug therapy development: - Pharmacological interventions to optimize the risk-benefit-ratio for patients and sustainable drug use

Research Research programs Academic drug therapy development:

Our mission

We aim to develop innovative pharmacotherapeutic treatment strategies and drug development strategies across the full drug life-cycle, from a societal perspective.

Goals

See some of the most important goals for this research program.

Listen

Goals

To establish a well-functioning academic research program and ecosystem.
To disseminate academic drug development knowledge.
To develop novel pharmacotherapeutic and repurpose treatments aligned with the respective research programs.
To develop alternative and optimized dosing strategies for existing treatments.
To develop novel model-informed dosing and drug development methodologies.
To develop novel drug production platform technologies.
To develop affordable and accessible pharmacotherapeutic treatments.
To improve clinical trial design and analysis with a focus on academic drug development.
To guide regulatory decision-making on (academic) drug development.

Research groups contributing to this research program

Cancer pharmacology

Nielka van Erp's research group focuses on describing, explaining, understanding and modifying the pharmacokinetics of oral anticancer drugs.

Inflammatory skin diseases

Elke de Jong's research group aims at improving care, treatment, translational research, implementation and eduction regarding patients with inflammatory skin diseases.

Translational cell and gene therapy for rare diseases

Gerty Schreibelt's research group focuses on acceleration of the translation of preclinical research into clinical implementation of cell and gene-based therapies for rare diseases.

Spokesperson

dr. Rob ter Heine

contact form